SCHEMBL31350456

SCHEMBL31350456

Nc1nc(Cl)nc2nc(-c3ccccc3)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.48
▸ HPGD P15428 3/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ NLRP3 Q96P20 1/20 0.48
▸ KDM4E B2RXH2 3/20 0.47
▸ LMNA P02545 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ ADORA1 P30542 5/20 0.46
▸ ADORA2A P29274 5/20 0.46
▸ ASIC3 Q9UHC3 1/20 0.43
▸ LIMK1 P53667 1/20 0.42
▸ HSP90AA1 P07900 2/20 0.42
▸ HSP90AB1 P08238 1/20 0.42
▸ MAPT P10636 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ AURKA O14965 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29506378 0.84 MEN1 (0.50) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL20256401 0.84 MEN1 (0.50) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL13040779 0.82 NLRP3 (0.61) ALDH1A1HPGDSMN1; SMN2NLRP3KDM4E
SCHEMBL31350565 0.76 HTT (0.46) ALDH1A1HPGDSMN1; SMN2KDM4ELMNA
SCHEMBL20256135 0.72 ADORA1 (0.49) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL13040787 0.71 NLRP3 (0.57) MEN1KMT2ASMN1; SMN2NLRP3KDM4E
SCHEMBL19876625 0.71 DHFR (0.71) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL29487320 0.70 DCPS (0.63) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL1620592 0.70 DCPS (0.63) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL3325825 0.69 ACHE (0.46) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743462-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2026-05-20 — — EP disclosed
WO-2025012643-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2025-01-16 — — WO disclosed
Send feedback